SCHEMBL31729173

SCHEMBL31729173

[2H]C([2H])([2H])Oc1cc(-c2ccc(F)c(Cl)c2F)c2ncnc(N)c2c1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK1 P49759 4/20 0.35
▸ EIF2AK3 Q9NZJ5 6/20 0.34
▸ EPHB4 P54760 4/20 0.34
▸ EGFR P00533 3/20 0.32
▸ SRC P12931 3/20 0.32
▸ ABL1 P00519 2/20 0.32
▸ HCK P08631 2/20 0.32
▸ KDR P35968 2/20 0.32
▸ PIK3CB P42338 2/20 0.32
▸ MTOR P42345 2/20 0.32
▸ PIK3CG P48736 2/20 0.32
▸ PRKDC P78527 2/20 0.32
▸ PI4KB Q9UBF8 2/20 0.32
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CA P42336 1/20 0.32
▸ PDE5A O76074 1/20 0.32
▸ LIMK1 P53667 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ ERBB2 P04626 1/20 0.31
▸ FYN P06241 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728591 0.92 EIF2AK3 (0.39) CLK1EIF2AK3EPHB4EGFRSRC
SCHEMBL31728559 0.84 CLK1 (0.33) CLK1EIF2AK3EPHB4PDE5A
SCHEMBL31727944 0.81 KHK (0.38) CLK1EIF2AK3EPHB4EGFRSRC
SCHEMBL31728213 0.80 EIF2AK3 (0.38) CLK1EIF2AK3EPHB4EGFRSRC
SCHEMBL31728133 0.79 CLK1 (0.36) CLK1EIF2AK3EPHB4EGFRSRC
SCHEMBL31728018 0.76 CLK1 (0.36) CLK1EIF2AK3EPHB4EGFRSRC
SCHEMBL31727792 0.76 PDCD1LG2 (0.36) CLK1EIF2AK3EPHB4EGFRSRC
SCHEMBL31728476 0.74 PDE5A (0.35) EPHB4EGFRSRCABL1HCK
SCHEMBL31729163 0.73 CLK1 (0.37) CLK1EPHB4EGFRSRCABL1
SCHEMBL31728069 0.73 CLK1 (0.39) CLK1PI4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback